Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Approval
|
Falling Comet
883.7500
-16.95
(
-1.88
%)
NSE
Jan 14, 2026
15:31 PM
Volume:
728.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
12 Aug 2024
US FDA Approval
883.75
-1.88%
ZYDUS LIFESCIENCES L
Accumulate:
Zydus Lifesciences Ltd.
by
Prabhudas Lilladhar
Target: 1305
Target
Prabhudas Lilladhar
Number of FII/FPI investors decreased from 707 to 682 in Dec 2025 qtr
More from Zydus Lifesciences Ltd.
Recommended
Nifty 50 outlook: Hopes rise for 2026 after a volatile year
The Baseline |
15 Jan 2026, 01:13PM
The top five: Analysts pick their winners for Q3
The Baseline |
15 Jan 2026, 11:06AM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020, 01:51PM